Containing a snapshot of the overall market analysis, each Executive Summary provides a description of the scope and methodology used in the report; a summary of results including market size and market growth; a sampling of charts and graphs when available; and a brief look at the trends shaping the market.

The report from which this Executive Summary is compiled is World Market for Prescription Orthopedic Drugs, and the full study abstract is as follows:

The orthopedic drug market is a highly competitive market and, in some areas, the competitive environment is being shaped by increasing levels of generic competition. Several large pharmaceutical companies compete in the orthopedic drug market, including Abbott, Eli Lilly, GlaxoSmithKline, Merck, Novartis, and Pfizer among others, and several other suppliers, such as Serono, NovoNordisk, Amgen, and Genentech are developing or offering products in more niche market areas.

For the purposes of this study, the world market for orthopedic drugs has been segmented in a few general treatment segments:

• Arthritis Treatments
• Osteoporosis, Paget’s Disease, and Other Bone Loss Treatments
• Growth Disorder Treatments
• Other Orthopedic Treatments

Related Reports:
Snapshots US Pharmaceuticals 2009
Chiropractor Offices
Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis
Pharmaceuticals Industry Report
Pharmaceutical Industry in Mexico
Antipsychotics Market Forecast
Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes
Prescription Drug Wholesaling in the US - Industry Risk Rating Report
Orthopedics: Global Industry Guide
Antidepressants Market Forecast